Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

InnovAge Holding (INNV) EBT (2020 - 2025)

InnovAge Holding's EBT history spans 6 years, with the latest figure at $12.5 million for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 192.56% year-over-year to $12.5 million, compared with a TTM value of $5.1 million through Dec 2025, up 119.56%, and an annual FY2025 reading of -$34.0 million, down 55.95% over the prior year.
  • EBT for Q4 2025 was $12.5 million at InnovAge Holding, up from $7.9 million in the prior quarter.
  • The five-year high for EBT was $12.5 million in Q4 2025, with the low at -$17.2 million in Q3 2022.
  • Average EBT over 5 years is -$4.9 million, with a median of -$6.8 million recorded in 2022.
  • Year-over-year, EBT plummeted 683.4% in 2022 and then skyrocketed 249.19% in 2025.
  • Tracing INNV's EBT over 5 years: stood at $2.3 million in 2021, then plummeted by 683.4% to -$13.5 million in 2022, then skyrocketed by 72.3% to -$3.7 million in 2023, then crashed by 260.97% to -$13.5 million in 2024, then surged by 192.56% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for INNV's EBT are $12.5 million (Q4 2025), $7.9 million (Q3 2025), and -$4.2 million (Q2 2025).